Clinical trial

Gadobutrol Magnevist-controlled Body Study

NCT01050829

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE3

Study timeline

Study start (unknown)2010-01-01Date precision: month

Registry last updated2014-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Magnetic Resonance Imagingunresolved

Interventions

Gadobutrol (Gadovist, BAY86-4875)DRUG

Gadopentetate Dimeglumine (Magnevist, BAY86-4882)DRUG

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

SeoulSouth Korea2 ShanghaiChina2 BeijingChina1 NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01050829 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.